AR and hyperandrogenism: The role of hyperandrogenism in the ovulation defects observed in PCOS-like mouse models was elegantly demonstrated by comparing global and cell-specific androgen receptor (AR) knockout mouse lines treated with dihydrotestosterone (DHT) or with AMH.